1Seghatchian J. The potential usefulness of thrombelastography in quality monitoring and quality improvement of blood components [J]. Transfus Apher Sci, 2009,41 (3) : 227-228.
2SpineHa PC,Holcomb JB. Resuscitation and transfusion principles for traumatic hemorrhagic shock[J]. Blood Rev, 2009,23 (6) : 231- 240.
3Miehelson AD. Methods for the measurement of platelet function [J]. Am J Cardiol,2009,103(3 Suppl):20-26.
4Cosmi B, Alatri A,Cattaneo M, et al. Assessment of the risk of bleeding in patients undergoing surgery or invasive procedures: guidelines of the Italian society for haemostasis and thrombosis(SISET)[J]. Thromb Res,2009,124(5) :e6-12.
5Gurbel PA, Bliden KP, Saucedo JF, et al. Bivalirudin and elopi- dogrel with and without eptifibatide for elective stenting: effects on platelet function, thrombelastographie indexes, and their rela- tion to periprocedural infaretion[J]. J Am Coll Cardiol, 2009,53 (8) :648-657.
6Westbrook A J, Olsen J, Bailey M, et al. Protocol based on throm- boelastograph(TEG) out-performs physician preference using la- boratory coagulation tests to guide blood replacement during and after cardiac surgery:a pilot study[J]. Heart Lung Cite, 2009,18 (4) :277-288.
7de Pietri L, Masetti M, Montalti R, et al. Use of recombinant fac- tor lX and thromboelastography in a patient with hemophilia B un- dergoing liver transplantation : a case report[J]. Transplant Proc, 2008,40(6) : 2077-2079.
8Tsou MY. Evaluation of the platelet function analyzer(PFA-100) vs,the thromboelast0gram(TEG) in the clinical setting [J]. Aeta Anaesthesiol Taiwan,2009,47(3) : 107-109.
9Kashuk JL, Moore EE, Sabel A, et al. Rapid thrombelastography (γ-TEG)identifies hypercoagulability and predicts thromboembol- ic events in surgical patients[J]. Surgery, 2009,146 (4) : 764-772.
10Taneja R,Fernandes P, Marwaha G, et al. Perioperative coagula tion management and blood conservation in cardiac surgery: a ca nadian survey[J].J Cardiothorae Vasc Anesth, 2008,22 (5) : 662-669.
3RELATED ARTICLES, LINKSSWALLOW RA. Thromboelastography : potential bedside tool to assess the effects of antiplatelet therapy [J]. Platelets ,2006,17 (6) :385- 392.
4HOBSON AR, PETLEY GW. A novel fifteen minute test for assessment of individual time-dependent clotting responses to aspirin and elopidogrel using modified thrombelastography[ J]. 2007,18(7) :497-505.
6Craft RM, Chavez J J, Snider CC, et al. Comparison of modified Thrombelastograph and Plateletworks whole blood assays to optical platelet aggregation for monitoring reversal of clopidogrel inhibition in elective surgery patients. J Lab Clin Med, 2005 ; 145 (6):309-315.
7Miller BE, Tosone SR, Guzzetta NA, et al. Fibrinogen in children undergoing cardiac surgery: is it effective? Anesth Analg, 2004; 99 (5), 1341-1346.
8Fletcher B, Taylor Jr, Cheng-Hock Toh, et al. Towards definition, clinical and laboratory criteria, and a scoring system for disseminated intravascular coagulation. Thromb Haemost, 2001 ; 86 : 1327-1330.
9Slofstra SH,Spek CA, Ten Cate H. Disseminated intravascular coagulation. Hematol, 2003 ; 4 (5) : 295-302.
10Ten Cate H. Trombocytopenia: one of the markers of disseminated intravascular coagulation. Pathophysiol Haemost Thromb, 2003 , 33 (5-6) : 413-416.
